Genor Biopharma Holdings Ltd. has proposed a change of company name as part of a series of transactions, according to a recent announcement. The company, incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange, is involved in a substantial acquisition and other strategic plans.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.